SEARCH RESULT

Total Matching Records found : 382

Trade Talks with EU Put Drug Manufacturers on Edge by Keya Acharya

Their ongoing negotiations remain shrouded in secrecy, but there are already reports that India and the European Union (EU) will have a free-trade agreement ready by the end of August, and that they will be putting signatures to it before the end of 2010. Yet it is a potential development that is causing more nervous chatter than joyous jitters here in India, where drug manufacturers in particular have raised concerns over...

More »

RTE Act: some rights and wrongs by Pushpa M Bhargava

As it stands, the Right to Education Act has several flaws that will prevent its efficacious implementation. Several amendments are called for. Something that cannot work, will not work. This is a tautology applicable to the Right to Education (RTE) Act, which cannot meet the objectives for which it was enacted. There are several reasons for this. First, the Act does not rule out educational institutions set up for profit (Section 2.n.(iv))....

More »

Food for a billion by Nitin Sethi

On Wednesday, the National Advisory Council turned UPA's election promises into firm deliverables under the National Food Security Bill. That was a tough one to resolve itself. But it's a job half done as yet. The Sonia Gandhi-led NAC is now going to get into a much more difficult arena. It has to figure out provisions for the act that hold administration and bureaucracy accountable for delivery and also ensure...

More »

It’s Not All Frivolity by Anuradha Raman

Mangalore air crash highlights two petitions highlighting safety violations in the Mangalore tabletop airport, dismissed by the Karnataka High Court in ’92 and by the Supreme Court in ’02 Apex court dismisses petition against mining in Niyamgiri hills in 2008; now a global focus point The same year, the apex court dismisses PIL against the building of the Commonwealth Games village on the Yamuna riverbed. Why has the UPA government, which loses no...

More »

Three firms rank highest on access to poor by Donald G. Mcneil Jr

GlaxoSmithKline, Merck and Novartis have taken the top three spots again on the Access to Medicine Index, which ranks pharmaceutical companies on how readily they make their products available to the world's poor. It was the second time the rankings, which were created in 2008, have been issued. This time, 95 per cent of the brand-name companies approached by the Dutch foundation that started the index agreed to provide information;...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close